Bone marrow MRD level (%)
| Treatment . | Ibr . | Ibr + R . | Ibr vs Ibr + R . | |||
|---|---|---|---|---|---|---|
| n . | LSMEAN (95% CI) . | n . | LSMEAN (95% CI) . | LSMEAN Difference . | P . | |
| 12 mo | 89 | 34.4 (29.9-39.0) | 88 | 18.5 (13.9-23.0) | 16.0 (9.6-22.4) | <.0001 |
| 24 mo | 75 | 19.8 (15.5-24.0) | 64 | 12.2 (7.5-16.8) | 7.6 (1.3-13.9) | .0180 |
| Treatment . | Ibr . | Ibr + R . | Ibr vs Ibr + R . | |||
|---|---|---|---|---|---|---|
| n . | LSMEAN (95% CI) . | n . | LSMEAN (95% CI) . | LSMEAN Difference . | P . | |
| 12 mo | 89 | 34.4 (29.9-39.0) | 88 | 18.5 (13.9-23.0) | 16.0 (9.6-22.4) | <.0001 |
| 24 mo | 75 | 19.8 (15.5-24.0) | 64 | 12.2 (7.5-16.8) | 7.6 (1.3-13.9) | .0180 |
LSMEAN is derived based on the analysis of covariance model with effect for treatment and baseline MRD level as a covariate. LSMEAN, least squares mean.